Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy
2007 ◽
Vol 14
(8)
◽
pp. 2221-2227
◽
2017 ◽
Vol 1
(Supplementary 1)
◽
pp. 0-0
2008 ◽
Vol 196
(1)
◽
pp. 64-69
◽
1996 ◽
Vol 88
(17)
◽
pp. 1204-1209
◽